Human Genome's Lupus Drug Shows Success in Trials; Shares Jump
Wednesday, June 17, 2009
A midstage trial of aInc. drug to treat a form of lupus showed sustained ability to reduce flare-ups caused by the chronic, life-threatening autoimmune disease in combination with standard medical care, the company said.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms